Introduction
============

Vitamin D has a number of anti-tumor properties, including inhibition of cell proliferation and induction of apoptosis and differentiation \[[@B1]\]. In observational studies of breast cancer and vitamin D status, women in the highest quantile of circulating vitamin D had a 45% reduced risk of breast cancer compared to those in the lowest quantile \[[@B2]\].

However, the effect of vitamin D on mammographic density (MD), one of the strongest predictors of breast cancer, remains unclear. MD refers to the relative proportions of radiolucent fat and radiodense fibroglandular tissue within the breast on mammography \[[@B3]\]. Serum 25-hydroxyvitamin D \[25(OH)D\] provides an integrated measure of vitamin D status from diet, supplements, and sunlight exposure and is considered the best indicator of vitamin D body stores \[[@B4]\]. We examined the association between MD and serum 25(OH)D in a cross-sectional study of racially/ethnically diverse women undergoing screening mammography.

Methods
=======

We enrolled 195 women age 40--60 years without a personal history of breast cancer to the New York City Multiethnic Breast Cancer Project from January 2007 to April 2008. Participants were enrolled at their routine screening mammography visits at Long Island College Hospital (LICH) in Brooklyn, New York, as previously described \[[@B5]\]. All participants completed in-person interviews providing information on demographics and breast cancer risk factors and consented to allow study investigators access to their mammograms; 120 (62%) participants provided a blood sample and 114 were evaluable for serum 25(OH)D measurements \[[@B5]\]. The study protocol was approved by the Institutional Review Boards of LICH, Long Island University and Columbia University Medical Center (CUMC).

We measured serum 25(OH)D in batched, archived specimens by Diasorin radioimmuoassay (Stillwater, MN). Interassay precision for quality controls were 14% and 18% at 15 ng/ml and 48 ng/ml, respectively. We evaluated digitized mammograms for dense area (cm^2^), non-dense area (cm^2^), and percent density (dense area divided by total breast area) on cranial-caudal images using Cumulus software, as previously described \[[@B5]\]. The Pearson correlation coefficients for repeated readings of a randomly selected 10% subset of mammograms were 0.99 and 0.9 for breast area and dense area, respectively.

We performed 2-sample t-tests and chi-square tests to determine whether the distribution of selected breast cancer risk factors differed by serum 25(OH)D. We used linear regression models to investigate the association of MD with serum 25(OH)D. We assessed for confounding by using the change in estimate criteria of 10% or more for estimates of the association between serum 25(OH)D and MD after adding each known potential confounding variable to the bivariable model. The multivariable models included age, race/ethnicity, education, body mass index (BMI, kg/m^2^), ever breast-feeding, and season of blood draw (January-March, April-June, July-September, October-December). We also conducted stratified analyses based upon menopausal status, BMI (≤30 vs. \>30 kg/m^2^), and season (January-June vs. July-December). All statistical analyses were conducted using SAS version 9.2 (Cary, NC).

Findings
========

The median serum 25(OH)D for the entire sample was 22 ng/ml (range 8--66 ng/ml). Forty-seven (41%) women had serum 25(OH)D levels in the deficient range (\<20 ng/ml), 32 (28%) in the insufficient range (20--29 ng/ml), and 35 (31%) in the sufficient range (≥30 ng/ml). Baseline characteristics according to groups above and below the median serum 25(OH)D are shown in Table [1](#T1){ref-type="table"}. In univariable analysis, having a serum 25(OH)D above the median was associated with white race, higher educational level, ever breast feeding, blood draw during the summer, and a trend toward lower dense area (p = 0.086).

###### 

Baseline characteristics of New York city multiethnic breast cancer project (N = 114) by serum 25(OH)D levels above and below the median; 2007-2008

  **Characteristic**                                     **Total (N = 114)**   **Serum 25(OH)D**   **P-value**^**b**^  
  ----------------------------------------------------- --------------------- ------------------- -------------------- -------
  Mean age at interview, years (SD)                          50.0 (5.8)           49.4 (5.9)           50.7 (5.6)       0.233
  Race/ethnicity, N (%)                                                                                                    
    White                                                      28 (25)              8 (14)              20 (36)         0.008
    African American                                           47 (41)              32 (54)             15 (27)            
    African Caribbean                                          21 (18)              9 (15)              12 (22)            
    Hispanic/Other                                             18 (16)              10 (17)              8 (15)            
  Menopausal status, N (%)                                                                                                 
    Pre/perimenopausal                                         73 (64)              41 (69)             32 (58)         0.209
    Postmenopausal                                             41 (36)              18 (31)             23 (42)            
  Highest level of education, N (%)                                                                                        
    ≤High school                                               34 (30)              22 (37)             12 (22)         0.045
    Some college/associate degree                              35 (31)              20 (34)             15 (27)            
    ≥College degree                                            45 (39)              17 (29)             28 (51)            
  Mean body mass index, kg/m^2^ (SD)                         29.2 (6.3)           30.3 (6.1)           28.1 (6.3)       0.055
  First-degree family history of breast cancer, N (%)                                                                      
    Yes                                                        17 (15)              10 (17)              7 (13)         0.554
    No                                                         96 (85)              49 (83)             47 (87)            
  Mean age at menarche, years (SD)                           12.5 (1.8)           12.3 (1.8)           12.6 (1.8)       0.366
  Mean parity, N (SD)                                         1.6 (1.4)            1.5 (1.5)           1.7 (1.3)        0.534
  Mean age at first live birth, years (SD)                   22.6 (6.8)           21.7 (6.9)           23.5 (6.7)       0.248
  Ever breast fed, N (%)                                                                                                   
    Yes                                                        46 (40)              17 (29)             29 (53)         0.009
    No                                                         68 (60)              42 (71)             26 (47)            
  Ever hormonal birth control use, N (%)                                                                                   
    Yes                                                        78 (68)              43 (73)             35 (64)         0.289
    No                                                         36 (32)              16 (27)             20 (36)            
  Season of blood draw, N (%)                                                                                              
    January-March                                              62 (54)              34 (58)             28 (51)         0.017
    April-June                                                 29 (25)              19 (32)             10 (18)            
    July-September                                             19 (17)              6 (10)              13 (24)            
    October-December                                            4 (4)                0 (0)               4 (7)             
  Mean percent density, % (SD)                               12.9 (11.4)           13 (11.1)          12.7 (11.8)       0.875
  Mean dense area, cm^2^ (SD)                                17.4 (14.7)          19.7 (16.1)         14.9 (12.8)       0.086
  Mean non-dense area, cm^2^ (SD)                            148 (82.3)           158 (78.2)           137 (85.9)       0.185

^a^Median 25(OH)D of 22 ng/ml.

^b^P-value based upon 2-sample t-tests for continuous variables and chi-square tests for categorical variables.

After adjusting for age, race/ethnicity, education, BMI, ever breast feeding, and season of blood draw, we found no association between 25(OH)D and the different measures of MD (Table [2](#T2){ref-type="table"}), even when stratified by menopausal status and BMI. We did, however, observe a trend toward lower percent density during the late summer (July-September), when the highest levels of serum 25(OH)D were observed. Stratified analysis by season (Table [3](#T3){ref-type="table"}) revealed that serum 25(OH)D was inversely associated with dense area in multivariable analysis (p = 0.034) during the months of July-December.

###### 

**Multivariable linear regression estimates of percent density (%), dense area (cm**^**2**^**), and non-dense area (cm**^**2**^**), New York city multiethnic breast cancer project, 2007-2008**

  **Characteristic**                     **β coefficient**   **95% CI**   **P-value**  
  ------------------------------------- ------------------- ------------ ------------- --------
  *Percent Density (%)*                                                                
  Serum 25(OH)D (ng/ml)                       −0.013           −0.188        0.161      0.880
  Age at mammogram (years)                    −0.576           −0.921       −0.230      0.001
  Race/ethnicity                                                                           
    White                                    Reference                                     
    African American                           1.762           −3.831        7.355      0.533
    African Caribbean                          3.169           −3.274        9.613      0.332
    Hispanic/Other                            −2.094           −8.860        4.672      0.541
  Education                                                                                
    ≤High school                              −2.017           −7.157        3.123      0.438
    Some college/associate degree             −3.646           −8.600        1.308      0.147
    Bachelor, master, doctoral degree        Reference                                     
  Body mass index (kg/m^2^)                   −0.503           −0.873       −0.133      0.008
  Ever breast feeding                                                                      
    Yes                                        1.038           −3.015        5.091      0.612
    No                                       Reference                                     
  Season of blood draw                                                                     
    January-March                            Reference                                     
    April-June                                 0.761           −3.983        5.505      0.751
    July-September                            −5.398          −11.259        0.462      0.071
    October-December                          −5.464          −16.201        5.274      0.315
  *Dense Area (cm*^*2*^*)*                                                             
  Serum 25(OH)D (ng/ml)                       −0.094           −0.332        0.143      0.432
  Age at mammogram (years)                    −0.624           −1.101       −0.146      0.011
  Race/ethnicity                                                                           
    White                                    Reference                                     
    African American                           5.421           −2.299       13.142      0.167
    African Caribbean                          5.838           −2.899       14.576      0.188
    Hispanic/Other                            −2.643          −11.985        6.700      0.576
  Education                                                                                
    ≤High school                              −0.243           −7.254        6.767      0.945
    Some college/associate degree             −3.547          −10.372        3.278      0.305
    Bachelor, master, doctoral degree        Reference                                     
  Body mass index (kg/m^2^)                   −0.170           −0.680        0.341      0.511
  Season of blood draw                                                                     
    January-March                            Reference                                     
    April-June                                 3.430           −3.128        9.988      0.302
    July-September                            −6.680          −14.763        1.403      0.104
    October-December                          −6.718          −21.564        8.128      0.371
  *Non-Dense Area (cm*^*2*^*)*                                                         
  Serum 25(OH)D (ng/ml)                        0.209           −0.823        1.242      0.688
  Age at mammogram (years)                     3.346           1.302         5.390      0.002
  Race/ethnicity                                                                           
    White                                    Reference                                     
    African American                          12.640          −20.455       45.735      0.533
    African Caribbean                          6.186          −31.943       44.315      0.748
    Hispanic/Other                            −2.090          −42.125       37.946      0.918
  Education                                                                                
    ≤High school                              22.854           −7.560       53.269      0.139
    Some college/associate degree             21.506           −7.809       50.821      0.149
    Bachelor, master, doctoral degree        Reference                                     
  Body mass index (kg/m^2^)                    7.142           4.952         9.331      \<.001
  Ever breast feeding                                                                      
    Yes                                       −17.582         −41.566        6.402      0.149
    No                                       Reference                                     
  Season of blood draw                                                                     
    January-March                            Reference                                     
    April-June                                −0.074          −28.145       27.997      0.996
    July-September                            23.080          −11.597       57.757      0.190
    October-December                           8.404          −55.132       71.940      0.794

###### 

**Multivariable linear regression estimates of dense area (cm**^**2**^**) stratified by season of blood draw (January-June, July-December), New York city multiethnic breast cancer project, 2007-2008**

  **Characteristic**                     **β coefficient**   **95% CI**   **P-value**  
  ------------------------------------- ------------------- ------------ ------------- -------
  *January-June (N = 91)*                                                              
  Serum 25(OH)D (ng/ml)                       −0.046           −0.338        0.246      0.757
  Age at mammogram (years)                    −0.813           −1.421       −0.205      0.009
  Race/ethnicity                                                                           
    White                                    Reference                                     
    African American                           6.014           −3.463       15.491      0.210
    African Caribbean                          8.406           −2.912       19.724      0.143
    Hispanic/Other                            −2.480          −13.841        8.882      0.665
  Education                                                                                
    ≤High school                              −1.405           −9.837        7.027      0.741
    Some college/associate degree             −4.541          −13.109        4.026      0.295
    Bachelor, master, doctoral degree        Reference                                     
  Body mass index (kg/m^2^)                    0.056           −0.540        0.653      0.851
  *July-December (N = 23)*                                                             
  Serum 25(OH)D (ng/ml)                       −0.254           −0.487       −0.022      0.034
  Age at mammogram (years)                    −0.272           −0.711        0.167      0.204
  Race/ethnicity                                                                           
    White                                    Reference                                     
    African American                           5.525           −1.281       12.332      0.103
    African Caribbean                          1.711           −5.984        9.406      0.639
    Hispanic/Other                             3.002           −8.678       14.682      0.588
  Education                                                                                
    ≤High school                               0.492           −6.070        7.053      0.874
    Some college/associate degree             −1.411           −7.427        4.604      0.621
    Bachelor, master, doctoral degree        Reference                                     
  Body mass index (kg/m^2^)                   −0.892           −1.323       −0.462      0.001

Discussion
==========

Overall, we observed a non-significant trend toward lower dense area in participants with higher serum 25(OH)D, which was no longer significant after adjustment for BMI and other confounders. However, during the months of July-December, we observed a significant inverse association between serum 25(OH)D and dense area, which may be a better a measure of MD in obese women.

A recent systematic review of fourteen studies examining the association between vitamin D and MD \[[@B6]\] included twelve cross-sectional studies \[[@B7]-[@B18]\] and two prospective studies \[[@B19],[@B20]\]. Nine studies assessed vitamin D status by dietary and supplement intake \[[@B12]-[@B20]\] and five studies by circulating 25(OH)D levels \[[@B7]-[@B11]\]. Only four studies considered dense area as a measure of MD \[[@B7],[@B10],[@B11],[@B15]\] and five studies included populations which were diverse by race and ethnicity \[[@B10],[@B11],[@B15]-[@B17]\].

Five out of nine studies which assessed dietary intake of vitamin D reported a significant inverse association between vitamin D and MD \[[@B8],[@B13]-[@B15],[@B18]\]. When stratified by menopausal status, much of the association was limited to premenopausal women \[[@B13]-[@B15]\]. In a sub-study of the Women's Health Initiative (WHI), no association was observed between vitamin D or calcium intake and MD among postmenopausal women, however, supplemental vitamin D use was associated with lower density in younger women \[[@B17]\]. Of note, we did not observe an association between 25(OH)D and MD when stratified by menopausal status, however, this subgroup analysis was limited by our relatively small sample size.

More recent studies that assessed serum 25(OH)D levels in relation to MD have reported null findings \[[@B7]-[@B11]\]. One study found that women in the highest quartile of serum 25(OH)D had the lowest density measurements, although no significant relationship between serum 25(OH)D levels and MD was reported \[[@B7]\]. No association was found between circulating levels of 25(OH)D and MD among postmenopausal women in the Nurses' Health Study. However, women in the highest tertile of MD and lowest tertile of plasma 25(OH)D had a 4-fold increased risk of breast cancer compared to women with the lowest MD and highest plasma 25(OH)D \[[@B9]\].

A limitation of all of these studies was that the blood collections for serum 25(OH)D and mammograms were not conducted at the same time point (with time intervals varying from 1--8 years), unlike our study in which the blood sample and mammogram were collected on the same day. Although most studies adjusted for time between blood draws and mammograms, this may not account for the seasonal variation in vitamin D status. Brisson *et al.* reported synchronized seasonal variations of MD and 25(OH)D blood levels, demonstrating that the lowest breast density was observed in early December, approximately 4 months after peak serum 25(OH)D \[[@B8]\]. During July-December when serum 25(OH)D are at their highest levels, we observed an inverse association between vitamin D status and dense area.

We measured serum 25(OH)D in batched archived blood samples using the well-validated Diasorin radioimmunoassay. Prior research has demonstrated that circulating 25(OH)D is very stable in serum with long-term storage \[[@B21]\]. There is increasing use of LS-MS technology, which allows for quantification of 25(OH)D~2~ and 25(OH)D~3~ separately. However, the clinical utility of separately measuring D2 and D3, as opposed to total 25(OH)D, is uncertain \[[@B21]\].

Percent density is a measurement of the dense breast tissue relative to non-dense, primarily fat tissue, and as such percent density partly accounts for differences in breast size. However, it may underestimate MD in obese women with large amounts of fat. We also assessed dense area and non-dense area, which were only evaluated in four other studies as measures of MD \[[@B7],[@B10],[@B11],[@B15]\]. Given that the mean BMI of our study population was relatively high at 29.2 kg/m^2^, dense area may be a more accurate way of assessing breast cancer risk in these women. Obesity has been positively associated with postmenopausal breast cancer risk \[[@B22]\] and is also inversely related to vitamin D status. People who are overweight and obese have a higher prevalence of vitamin D deficiency compared to lean individuals due to decreased bioavailability of fat-soluble vitamin D and sequestration in adipose tissue \[[@B23]\].

The main limitation of our study is the relatively small sample size. Strengths of our study include the large African American sample, comprehensive examination of risk factors, adjustment for season, use of an objective measure of vitamin D exposure, collection of blood and mammograms at the same time point, and assessment of three different measures of MD. In particular, dense area is less studied and may be more relevant in a study population with a high prevalence of obesity.

In conclusion, serum 25(OH)D status, a potentially modifiable breast cancer risk factor, was not associated with MD in this cross-sectional study. However, we did observe an inverse association with dense area based upon season, which needs to be replicated in larger studies. Since a one-time measurement of serum 25(OH)D may not reflect lifetime exposure to vitamin D, future prospective studies should examine changes in vitamin D exposure over time in relation to MD and breast cancer risk, since few longitudinal studies to date have documented changes in vitamin D status with changes in MD over time \[[@B24]\].
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